These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. Nakashima C; Kato M; Otsuka A J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825 [TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19). Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184 [TBL] [Abstract][Full Text] [Related]
5. [Skin manifestations of COVID-19 and after COVID-19 vaccination]. Reinhart M; Metze D; Braun SA Hautarzt; 2022 Jun; 73(6):434-441. PubMed ID: 35477785 [TBL] [Abstract][Full Text] [Related]
6. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Fernández-Lázaro D; Garrosa M Viruses; 2021 Sep; 13(10):. PubMed ID: 34696346 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis. Hinterseher J; Hertl M; Didona D J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206 [TBL] [Abstract][Full Text] [Related]
9. Covid-19 pandemic and the skin. Drenovska K; Schmidt E; Vassileva S Int J Dermatol; 2020 Nov; 59(11):1312-1319. PubMed ID: 32954488 [TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series. Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662 [TBL] [Abstract][Full Text] [Related]
12. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review. Fitzpatrick S; Cha S; Katz J; Migliorati C Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994 [TBL] [Abstract][Full Text] [Related]
13. Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital. Méndez Maestro I; Peña Merino L; Udondo González Del Tánago B; Aramburu González A; Orbea Sopeña A; Sánchez De Vicente J; Ratón Nieto JA; Acebo Mariñas E; Gardeazabal García J Int J Dermatol; 2020 Nov; 59(11):1353-1357. PubMed ID: 32970840 [TBL] [Abstract][Full Text] [Related]
14. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Genovese G; Moltrasio C; Berti E; Marzano AV Dermatology; 2021; 237(1):1-12. PubMed ID: 33232965 [TBL] [Abstract][Full Text] [Related]
15. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421 [TBL] [Abstract][Full Text] [Related]
16. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? Lipsker D Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature. Dondi A; Sperti G; Gori D; Guaraldi F; Montalti M; Parini L; Piraccini BM; Lanari M; Neri I Eur J Pediatr; 2022 Oct; 181(10):3577-3593. PubMed ID: 35948654 [TBL] [Abstract][Full Text] [Related]
18. Severe urticarial rash as the initial symptom of COVID-19 infection. Pagali S; Parikh RS BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 and cutaneous manifestations: A review of the published literature. Martora F; Villani A; Fabbrocini G; Battista T J Cosmet Dermatol; 2023 Jan; 22(1):4-10. PubMed ID: 36342945 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review. Cestari SDCP; Cestari MDCP; Marques GF; Lirio I; Tovo R; Cruz Silva Labriola I An Bras Dermatol; 2023; 98(4):466-471. PubMed ID: 36964106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]